Sigma-Aldrich Pte Ltd
326 Safety Data Sheets and Chemical Risk Assessments supplied by Sigma-Aldrich Pte Ltd.
- DL-Threo-PDMP, Hydrochloride
- DNP-Hemocyanin Conjugate, Keyhole Limpet
- DSP, Water-Soluble
- Dual DYRK/CLK Inhibitor, Cpd 23
- Dynamin Inhibitor V, 34-2
- EIF2-GTP-TRNAiMet Ternary Complex Inhibitor Negative Control, NCPdCPU
- EIF4E/EIF4G Interaction Inhibitor II, 4E1RCat
- Epoxidized Soya Bean Oil
- Epoxomicin, Synthetic
- ERK Activation Inhibitor Peptide I, Cell-Permeable
- ERK Inhibitor II, FR180204
- Ethyl Propionate
- Ezh2 Inhibitor III, SAH-EZH2
- FGF/VEGF Receptor Tyrosine Kinase Inhibitor, PD173074
- FGFR Inhibitor, SSR128129E
- Filastatin
- Flt3 Inhibitor IV
- Fluvastatin, Sodium Salt
- Formyl Peptide Receptor-Like 1 Antagonist, WRW4
- Freunds Incomplete Adjuvant, Modified
- Galactokinase Inhibitor, Cpd36
- Galectin-1, Human, Recombinant, E. Coli
- Galectin-3C, Human, Recombinant, E. Coli
- Gap Junction Enhancer, PQ7
- GGACK
- Glucagon-Like Peptide 1 Receptor Agonist II
- Glucokinase Activator III, Ro-28-1675
- Glutaminase Inhibitor, Compound 968
- Glycocholic Acid, Sodium Salt
- GM 6001, Negative Control
- Goat Anti-Human IgA, -Chain Specific Peroxidase Conjugate
- Goat Anti-Human IgE, -Chain Specific
- Goat Anti-Mouse IgM, H&L Chain Specific Peroxidase Conjugate
- Granzyme B Inhibitor I
- Granzyme B Inhibitor II
- GS-493
- GSK3 Inhibitor XIX, IM-12
- Guanosine 3,5-Cyclic Monophosphorothioate, -Phenyl-1,N2-Etheno-8-Bromo-, Rp-Isomer, Sodium Salt
- GW1929
- HA 1077, Dihydrochloride
- HCNT2 Inhibitor
- Hemoglobin, Bovine Erythrocytes
- Histone Deacetylase 8, HisTag, Human Recombinant, S. Frugiperda
- Histone Methyltransferase EZH2 Inhibitor, DZNep
- HMGB Inhibitor, Inflachromene
- HMTase Inhibitor IV, UNC0638
- HSP70 Activator II, YM-08
- Hyaluronic Acid, Bovine Trachea, Fluorescein-Labeled
- Hypochlorous Acid Fluorescent Probe, PIS
- I-BET726
- IKK Inhibitor VII
- IKK/TBK1 Inhibitor II, MRT67307
- IL-1R Antagonist
- InSolution TAPI-2
- InSolution Y-27632, Sterile-Filtered, Cell Culture-Tested
- Insulin-Like Growth Factor-I, Rat, Recombinant, E. Coli
- Interleukin-6, Human, Recombinant, E. Coli
- Interleukin-8, Human, Recombinant, E. Coli
- IRE1 Inhibitor I, STF-083010
- Iron Chelator IV, 21H7
- Isopropyl Alcohol
- JHDM Inhibitor VII, JIB-04
- JMJD Histone Demethylase Inhibitor III
- JNK Inhibitor I, (L)-Form, Cell-Permeable
- JNK Inhibitor III, Cell-Permeable
- JNK Inhibitor VIII
- JWH 015
- Kallikrein, Human Plasma
- Kir1.1 Inhibitor, VU591
- KLF5 Inhibitor, CID 5951923
- KT5720
- Lactimidomycin
- Lassomycin
- Leukadherin-1
- Lovastatin, Sodium Salt
- LSD1 Inhbitor VI, Cpd 2d
- LSF Inhibitor, FQI1
- Lumican, HisTag, CF, Mouse, Recombinant
- LY 303511
- LYP Inhibitor II, LTV-1
- Marimastat
- MAS 7
- Mcl-1 Inhibitor II
- MCT1 Inhibitor III
- MDM2/MDMX Dual Inhibitor, RO-5963
- Microcystin-LW, Microcystis Aeruginosa
- MK571, Sodium Salt
- MMP-13 Substrate, Fluorogenic
- MMP-14 Substrate I, Fluorogenic
- MMP-2 Substrate, Fluorogenic
- MMP-3, Catalytic Domain, Human, Recombinant, E. Coli
- MMP-9-Lipocalin-TIMP-1 Complex, Human Neutrophil
- MnTMPyP
- Monoacylglycerol Lipase Inhibitor, Cpd21
- Mouse Anti-Human IgG4, Fc Fragment Specific (HP6025)
- MPS1 Inhibitor II, MPS1-IN-3
- MPS1 Inhibitor, NMS-P715
- MyoVin-1
- N-Glycan Acceptor Substrate, Dabsylated Tetrapeptide, Asialo, Agalacto, Biantennary
- N-Octanoylsucrose